MeSH tree: C08.785.520.100.220
A new artificial intelligence tool that can create virtual representations of patients and predict individual health trajectories has been hailed a potential gamechanger for the clinical trial sector.
Nov 17, 2025
0
24
Researchers have developed a way to predict how lung cancer cells will respond to different therapies, allowing people with the most common form of lung cancer to receive more effective individualized treatment.
Oct 13, 2025
0
29
A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC). Patients in the study ...
Sep 29, 2025
0
26
A new study reveals that small cell lung cancer (SCLC) likely begins in basal stem-like cells rather than in neuroendocrine cells, marking a major shift in the understanding of this aggressive disease that is often associated ...
Sep 17, 2025
0
14
A study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with non–small cell lung cancer are ...
Sep 15, 2025
0
14
An international research team has shown that lung cancer cells can form functional synapses with neurons, effectively hijacking the body's neural circuits to grow faster. The finding reveals a startling new dimension of ...
Sep 10, 2025
0
34
Small cell lung cancer cells that metastasize to the brain cozy up to neurons and form working electrical connections, called synapses, according to a study led by Stanford Medicine researchers. The pulse of electrical signals ...
Sep 10, 2025
0
52
Lung cancer patients who take medications called GLP-1 receptor agonists—commonly prescribed for weight loss and diabetes management—fare better than those who don't, according to research led by Sai Yendamuri, MD, MBA, FACS, ...
Sep 9, 2025
0
11
In a move that could reshape drug discovery, researchers at Harvard Medical School have designed an artificial intelligence model capable of identifying treatments that reverse disease states in cells.
Sep 9, 2025
0
27
New research presented identifies interferon-induced transmembrane protein 3 (IFITM3) as a critical regulator of immunotherapy sensitivity in small cell lung cancer (SCLC), offering a promising new avenue for overcoming resistance ...
Sep 9, 2025
0
14
